1. Home
  2. SAMG vs XBIT Comparison

SAMG vs XBIT Comparison

Compare SAMG & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$10.18

Market Cap

76.4M

Sector

Finance

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.20

Market Cap

70.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
XBIT
Founded
2002
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
70.1M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
SAMG
XBIT
Price
$10.18
$2.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
56.4K
45.0K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
6.36%
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$91,358,000.00
N/A
Revenue This Year
$8.99
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$203.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.57
$2.09
52 Week High
$16.56
$3.44

Technical Indicators

Market Signals
Indicator
SAMG
XBIT
Relative Strength Index (RSI) 47.51 40.99
Support Level $9.69 $2.21
Resistance Level $10.63 $2.46
Average True Range (ATR) 0.29 0.07
MACD 0.01 -0.01
Stochastic Oscillator 46.46 11.76

Price Performance

Historical Comparison
SAMG
XBIT

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income, and cash, as well as non-traditional investment strategies including hedge funds, private equity funds, real estate, and commodities. The firm offers a full suite of complementary and customized family office services for families seeking comprehensive oversight of their financial affairs. The company derives revenues from Managed accounts, Silvercrest funds, Tax and family office services, and Fund administration. The firm generates the majority of its revenue from Managed Accounts.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: